Give Us A Kidney Or Give Us Death': The Kota Case And The State's Vanishing Moral Standing

WHEN THE INSTITUTION THAT CAUSED THE HARM ALSO DECIDES WHETHER IT COUNTS

Most euthanasia debates in India ask a single question: does an individual have the right to end unbearable suffering? The Kota case asks a harder one first - does a state that allegedly manufactured the suffering still get to act as the neutral authority deciding whether that suffering is real enough or premature enough, to warrant relief? The five women at New Medical College Hospital (NMCH), Kota, are not describing a natural illness they arrived with. They allege the hospital itself, through counterfeit medicines administered after ordinary C-sections, caused the kidney failure they are now living through.

Sixty-eight days and 32 rounds of dialysis later, they have asked President Droupadi Murmu for one of two things: a transplant or permission to be euthanised. The hospital's response is procedurally correct and ethically incomplete.

NMCH's Principal has said transplant eligibility requires 3 to 6 months of clinical observation before a patient can be categorised as having end-stage renal disease - a protocol that exists, in ordinary circumstances, to protect patients from premature, irreversible surgery. But this protocol is being applied by the same institution accused of causing the underlying injury. That is the tension a generic "right to die" framing misses entirely.

Indian law offers only a partial answer. The Supreme Court's 2018 Common Cause judgment recognised passive euthanasia and living wills as extensions of the right to a dignified life under Article 21 - but only for the terminally ill and only by withdrawing treatment, not administering death.

Active euthanasia, which is closer to what the Kota women are requesting, remains illegal. Their letter is legally almost certain to fail as a euthanasia petition. Read only that way, the story ends in a dead end. Read differently, it opens a different question entirely: who gets to be the "neutral clinician" here? Standard medical ethics assumes the party enforcing an observation period has no stake in the outcome.

NMCH does have a stake - every additional month of "clinical caution" is also a month further from any finding of institutional liability. The women are not just fighting kidney disease; they are fighting to be examined by an authority that isn't also the accused.

This is why the case belongs in GS4 rather than only GS2 or GS3: it is not simply a health-system failure story and not simply a right-to-die story. It is a conflict-of-interest problem wearing medical language - the same institution holds the power to diagnose, to delay and to be exonerated, all at once.

For the Mains aspirant, the transferable lesson is precise: whenever a state body evaluates a claim of its own negligence, procedural correctness (the 3-6 month rule, followed to the letter) can coexist with a complete failure of institutional ethics.

Compliance is not the same thing as trustworthiness and this case shows exactly why that distinction matters when lives, not files, are on the line.